Drug Discovery, Before and After AI - with Kristof Szalay of Turbine.ai - The AI in Business Podcast

Om avsnittet

The great and brilliant Dr. Kristof Szalay returns to the podcast. Dr. Szalay is CTO and Founder of Turbine.ai, a simulation-driven drug discovery company, delivering targeted cancer therapies to targeted patient populations. Today's episode topics include: how AI integrates with the phases of drug discovery, development, and generally applicable enterprise deployment challenges. Want to discover opportunities to integrate AI in your organization? Try Emerj Plus: emerj.com/p1

Drug Discovery, Before and After AI - with Kristof Szalay of Turbine.ai

Om avsnittet

Fler avsnitt

Preserving Field Service Expertise in the Age of AI - with Thomas Cottereau of Sightcall

Proving AI ROI in Pharma Marketing - with Kellen Winters of Novartis

Designing a Technical Workforce That Adapts at the Speed of AI - with Carrol Chang of Andela

Modernizing Enterprise GRC for Continuous Assurance - with Craig Unger of Hyperproof

Building the Foundations for Scalable Industrial AI - with Jeff Witt of GE Vernova

AI Content Governance Inside a Regulated Bank - with Stefan Zima of Raiffeisen Bank International AG

Reducing Alert Noise with AI in Enterprise IT - with Dhrubojyoti Das Deb of JPMorganChase

What Shared Intelligence Really Fixes in Enterprise AI - with John McMullan of Observe.ai

Inside the Shift Toward Smarter Automated CX - with Paul Cuglietta of Simplyhealth

Stop Overpaying for AI Power You Don't Need - with Melissa Ramey of Salesforce